Spinal Cord Hemorrhage Follow-up
- Author: Richard M Zweifler, MD; Chief Editor: Helmi L Lutsep, MD more...
Further Outpatient Care
After the patient is discharged from inpatient care, outpatient therapies continue. Medical treatments are frequently necessary for the late complications of spinal cord hemorrhage, especially spasticity, pain, and neurogenic bladder.
Further Inpatient Care
Once the patient with spinal cord hemorrhage has been treated, whether medically, via interventional radiology, or surgery, rehabilitation can begin. Usually this is accomplished in an inpatient rehabilitation setting.
Inpatient & Outpatient Medications
See the list below:
- Spasticity secondary to spinal cord hemorrhage is treated in similar ways to spasticity secondary to spinal cord injury or multiple sclerosis. Drugs include baclofen, tizanidine, and diazepam.
- Pain following spinal cord hemorrhage, other than pain directly secondary to spasticity, is treated similarly to neuropathic pain syndromes such as those in multiple sclerosis. Drugs include gabapentin, amitriptyline, and carbamazepine.
- Bladder complications of spinal cord hemorrhage are similar to those of spinal cord injury or multiple sclerosis. Consultation with a urologist may be necessary. Drug therapy with anticholinergic agents may be beneficial for reflex uninhibited bladder (ie, failure to store), and intermittent self-catheterization is essential in patients with inability to void (ie, failure to empty).
Avoid lumbar puncture in patients with hematologic disorders or in those treated with prescribed anticoagulants.
Prognosis varies but generally is correlated with severity of deficit. A more favorable outcome is seen in patients receiving prompt diagnosis and surgical intervention.
Barth A, Bougousslavsky J, Caplan LR. Spinal stroke syndromes. Barth A, Caplan LR, eds. Stroke Syndromes. New York: Cambridge University; 1995: 395-402.
Borm W, Mohr K, Hassepass V et al. Spinal hematoma unrelated to previous srugery. Analysis of 15 consecutive cases treated in a single institution within a 10-year period. Spine. 2004. 29:E555-E561.
Byrne TN, Benzel EC, Waxman SG. Diseases of the Spine and Spinal Cord. New York: Oxford University Press; 2000. Contemporary Neurology Series:
Domenicucci M, Ramieri A, Paolini S, et al. Spinal subarachnoid hematomas: our experience and literature review. Acta Neurochir (Wien). 2005 Jul. 147(7):741-50; discussion 750. [Medline].
Geibprasert S, Krings T, Apitzsch J, et al. Subarachnoid hemorrhage following posterior spinal artery aneurysm. A case report and review of the literature. Interv Neuroradiol. 2010 Jun. 16(2):183-90. [Medline].
Geldmacher DS, Bowen BC. Spinal cord vascular disease. Bradley WG, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in Clinical Practice Principles of Diagnosis and Management. 5th ed. Philadelphia, Pa: Butterworth-Heimann; 2008. 1285-93.
Groen RJM. Non-operative treatment of spontaneous spinal epidural hematomas: a review of the literature and a comparison with operative cases. Acta Neurochir (Wien). 2004. 146:103-110.
Gross BA, Du R, Popp AJ, Day AL. Intramedullary spinal cord cavernous malformations. Neurosurg Focus. 2010 Sep. 29(3):E14. [Medline].
Karavelis A, Foroglou G, Petsanas A, Zarampoukas T. Spinal cord dysfunction caused by non-traumatic hematomyelia. Spinal Cord. 1996 May. 34(5):268-71. [Medline].
Kreppel D, Antoniadis G, Seeling W. Spinal hematoma: a literature survey with meta-analysis of 613 patients. Neurosurg Rev. 2003. 26:1-49.
Leep Hunderfund AN, Wijdicks EF. Intramedullary spinal cord hemorrhage (hematomyelia). Rev Neurol Dis. 2009 Spring. 6(2):E54-61. [Medline].
Russell NA, Benoit BG. Spinal subdural hematoma. A review. Surg Neurol. 1983 Aug. 20(2):133-7. [Medline].